| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |